Research article
COVID-19-Induced Changes in the Fibrin Network of Pulmonary and Renal Microthrombi
Manuel Meneses-Flores, Jose S. Lopez-Gonzalez, Eduardo Becerril-Vargas, Saray Santos-Torres, Francina Bolaños-Morales et al.
Peer-reviewed · Open access · ISSN 2692-1537
International Journal of Coronaviruses
Basic, translational, clinical, epidemiological and public-health research on human and animal coronaviruses — spanning mechanisms, measurement, clinical and population effects, interventions, surveillance and preparedness.
- ISSN
- 2692-1537Online, ISSN Portal
- Publisher
- Open Access PubRancho Cordova, California
- Peer review
- Single-blind (double-blind on request)
- License
- CC BY 4.0Authors retain copyright
- DOI prefix
- 10.14302/issn.2692-1537Registered with Crossref
- Article processing charge
- USD 2,400Charged only after acceptance
65Published records
17Issues
5Volumes
2020First volume published
The journal archive currently contains 65 published records, including article content and notices retained as part of the scholarly record. No journal impact factor, acceptance rate or turnaround statistic is published.
The field after the emergency phase
Coronavirus science did not end when the emergency did
The emergency-response literature of 2020–2022 answered urgent descriptive questions. The questions that remain are mechanistic, longitudinal and comparative — and they belong to a virus family that is now a permanent part of the human and animal disease landscape.
An endemic virus family, not a single outbreak
Four human coronaviruses — 229E, NL63, OC43 and HKU1 — circulate seasonally and predate the pandemic. SARS-CoV-2 now circulates endemically and continues to diversify, while MERS-CoV remains an ongoing zoonotic hazard. Coronaviruses are a standing subject, not a closed episode.
From description to mechanism
The open problems are structural and immunological: how spike variation shifts receptor binding and neutralization escape, how prior exposure shapes later responses, how antiviral resistance emerges under selection, and how the virus persists in tissue. These require experimental work, not situation reports.
Preparedness is a standing requirement
Coronavirus diversity in animal reservoirs, the determinants of host range, and surveillance across the human–animal interface remain active research questions. Work that improves detection and prediction has value independent of any particular outbreak.
Scope
What the journal publishes
The journal considers basic, translational, clinical, epidemiological and public-health research on human and animal coronaviruses. The coronavirus focus must be substantive, and conclusions must remain within the limits of the evidence.
Biology and mechanisms
Virology, evolution and immunity
- Molecular virology and genome biology — replication, protein structure and function, virion assembly
- Viral evolution and genetics — mutation, recombination, selection and variant emergence
- Host–pathogen interaction — entry and receptor binding, tropism, innate immune evasion
- Immunology — neutralization, cellular immunity, immune memory, cross-reactivity, escape
Clinical and translational research
Disease, detection and countermeasures
- Antiviral development and resistance — mechanism of action, target validation, drug design
- Vaccine immunology — antigen design, correlates of protection, mucosal immunity
- Diagnostic methods — molecular and serological assay development, point-of-care detection
- Clinical manifestations, outcomes and interventions
Population and preparedness research
Epidemiology, surveillance and One Health
- Transmission, modeling and forecasting with transparent assumptions and validation
- Population effects, public-health interventions and preparedness
- Zoonotic ecology, animal coronaviruses and One Health surveillance
Scope boundary — read this before you submit
General infectious-disease, medical or public-health work with only incidental coronavirus relevance is normally out of scope. The journal does not consider unsupported treatment, vaccine, diagnostic, transmission or outbreak claims; routine records without sufficient analysis; or forecasts that omit assumptions, limitations and validation. The full fit criteria are on the Aims & Scope page.
From the archive
Research published in the journal
A selection of published work, with the full author list, issue and registered DOI for each. Every article is open access under CC BY 4.0 and free to read without registration.
Case report
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Tomiko Ryu, Yusuke Onozato, Ayano Umeda, Keiko Abe, Akio Mimori et al.
Research article
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Satadal Das, Debasmita Chatterjee, Krishnendu Paira
Short communication
Cytokine Profiling in COVID-19 Patients in a Tertiary Hospital in Saudi Arabia; the Pre-Storm Phase
Mayyadah Alabdely, Walter Conca, Morad AlKaff, Aziza Alonaizie, Futwan Almohanna
Short communication
Identify the Effects of Ultra Weak Light on Alphacoronavirus and Vero Cells
Hee-Chun Chung, Van Giap Nguyen, Hai-Quynh Do, Mi-Jung Park, Jeong Su Yang et al.
Research article
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Krittaecho Siripassorn, Angkana T. Huang, Ravee Nitiyanontakij, Sumonmal Uttayamakul, Chonticha Klungthong et al.
Editorial oversight
Who handles your manuscript
The editorial board has 17 members, with recorded affiliations in 13 countries; 15 have a registered ORCID iD you can check independently. Four members whose recorded expertise is closest to the journal’s scope are shown here.
Senior Research Fellow
Noguchi Memorial Institute for Medical Research, University of Ghana
Molecular epidemiology of infectious disease; host genetics
ORCID 0000-0001-8929-193X
Pharmaceutical Medicinal Chemistry
Faculty of Pharmacy, Tanta University, Egypt
Antiviral drug design, discovery and target validation
ORCID 0000-0003-3681-114X
MD, specialist in family and community medicine
Family and Community Medicine, Toledo, Spain
Clinical research and decision-making in primary care
ORCID 0000-0002-8463-171X
MD, MSci, PhD, Professor
Institute for Occupational Health of RNM, Skopje, North Macedonia
Occupational medicine, public health and workplace risk assessment
ORCID 0000-0003-1278-903X
Review, ethics and integrity
How a manuscript is assessed and what is published about it
The publishing terms below apply to every submission and link to the corresponding journal policies for full requirements.
- Peer-review model
- Single-blind (double-blind on request). Reviewer identities remain confidential; a double-blind review can be requested at submission. See the editorial policies.
- Originality screening
- Manuscripts are screened with Crossref Similarity Check before review.
- Research ethics
- Human-subject research requires Institutional Review Board approval and adherence to the Declaration of Helsinki; animal studies require IACUC oversight. Authorship follows the ICMJE criteria, conflicts of interest must be disclosed in full, and research articles carry a data availability statement.
- Corrections and retractions
- Corrections, expressions of concern and retractions are issued as separate, permanently posted notices under a COPE-aligned framework and remain part of the published record.
- Copyright and license
- Authors retain copyright. Articles are published under CC BY 4.0, with no embargo and no reader paywall.
- Registration and discovery
- DOIs are registered with Crossref under the prefix 10.14302/issn.2692-1537, and the journal is listed in the ISSN Portal. Published work is discoverable through Google Scholar and open-metadata services. Details, including what is and is not claimed, are on the indexing page.
- Editorial independence
- Decisions consider scope, scientific validity, originality, ethics, reporting quality and relevance to the journal’s readers. Article processing charges, membership and optional author services have no bearing on peer review, review speed or the decision.
Cost and process
What publication costs, and what happens after you submit
USD 2,400
Article processing charge, per accepted manuscript, all article types
- No submission fee and no review fee
- Charged only after a manuscript is accepted
- Peer-review coordination and editorial handling
- Copyediting, XML and PDF production, unlimited color figures
- DOI registration and metadata deposit
- Open access hosting under CC BY 4.0
Membership reduces the charge by 15–35% depending on tier. Full terms, payment methods and waiver criteria are on the article processing charges page.
1
Check scope
Confirm that coronavirus is the central research subject and that the methods and evidence support the claims. Read the full fit criteria before preparing files.
2
Prepare
Format to the author instructions, including the abstract limit, keywords, ethics statements and reference style.
3
Submit
Choose one approved route: ManuscriptZone, the publisher submission form, or editorial-office email. Do not create duplicate records through another route.
4
Review and decision
Single-blind external review, followed by an editorial decision based on scope, validity, originality, ethics, reporting quality and relevance. The APC is invoiced only after acceptance.
Author questions
Answers to the questions authors ask first
Is my manuscript within scope for the International Journal of Coronaviruses?
The journal considers basic, translational, clinical, epidemiological and public-health research on human and animal coronaviruses. Submissions may examine mechanisms, measurement, clinical or population effects, interventions, or preparedness. Coronavirus must remain the central research subject, and the methods and evidence must support the claims made.
Where is content from the journal registered and discoverable?
Articles are assigned DOIs under the Crossref prefix 10.14302/issn.2692-1537, and the journal is registered in the ISSN Portal under ISSN 2692-1537. Published articles are discoverable through Google Scholar and services that harvest open metadata. The journal is not currently listed in the Directory of Open Access Journals, Scopus, Web of Science or MEDLINE.
What peer-review model does the journal use?
Peer review is single-blind, with a double-blind option available on request at submission. Reviewer identities are confidential; author identities are known to reviewers unless the double-blind option is used. All submissions are screened with Crossref Similarity Check before review.
What does publishing cost, and when is the charge made?
The article processing charge is USD 2,400 per accepted manuscript, and it applies to all article types. There is no submission fee and no review fee, and the charge is raised only after a manuscript has been accepted. Members receive a 15–35% reduction depending on tier. Fees and membership have no bearing on peer review or on the editorial decision.
Who holds copyright, and under what license is work published?
Authors retain copyright in their work. Articles are published open access under the Creative Commons Attribution 4.0 International license, which permits reuse and redistribution in any medium provided the original work is properly cited.
Does the journal have an impact factor?
No. The journal is not covered by Web of Science and therefore has no Journal Impact Factor. No citation metric is published for the journal, and none should be quoted on its behalf.
Submit to the International Journal of Coronaviruses
Single-blind peer review, CC BY 4.0 open access with copyright retained by the authors, and a USD 2,400 article processing charge raised only on acceptance.